Diversified Trust’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Hold |
35,971
| – | – | 0.02% | 449 |
|
|
2025
Q1 | $597K | Buy |
35,971
+197
| +0.6% | +$3.27K | 0.01% | 519 |
|
|
2024
Q4 | $656K | Buy |
35,774
+3,187
| +10% | +$58.5K | 0.02% | 508 |
|
|
2024
Q3 | $501K | Buy |
32,587
+42
| +0.1% | +$646 | 0.01% | 583 |
|
|
2024
Q2 | $529K | Buy |
32,545
+1,680
| +5% | +$27.3K | 0.01% | 528 |
|
|
2024
Q1 | $571K | Buy |
30,865
+1,826
| +6% | +$33.8K | 0.02% | 476 |
|
|
2023
Q4 | $909K | Sell |
29,039
-571
| -2% | -$17.9K | 0.03% | 316 |
|
|
2023
Q3 | $617K | Buy |
29,610
+2,442
| +9% | +$50.9K | 0.02% | 386 |
|
|
2023
Q2 | $651K | Sell |
27,168
-5,089
| -16% | -$122K | 0.02% | 385 |
|
|
2023
Q1 | $607K | Buy |
32,257
+6,411
| +25% | +$121K | 0.02% | 397 |
|
|
2022
Q4 | $411K | Sell |
25,846
-478
| -2% | -$7.6K | 0.02% | 485 |
|
|
2022
Q3 | $431K | Buy |
26,324
+15
| +0.1% | +$246 | 0.02% | 437 |
|
|
2022
Q2 | $371K | Buy |
26,309
+5,464
| +26% | +$77.1K | 0.02% | 500 |
|
|
2022
Q1 | $505K | Sell |
20,845
-487
| -2% | -$11.8K | 0.02% | 443 |
|
|
2021
Q4 | $498K | Sell |
21,332
-2,196
| -9% | -$51.3K | 0.02% | 461 |
|
|
2021
Q3 | $391K | Buy |
23,528
+6,485
| +38% | +$108K | 0.01% | 484 |
|
|
2021
Q2 | $416K | Buy |
+17,043
| New | +$416K | 0.02% | 456 |
|
|
2015
Q1 | – | Sell |
-8,136
| Closed | -$258K | – | 492 |
|
|
2014
Q4 | $258K | Buy |
+8,136
| New | +$258K | 0.02% | 443 |
|
|
2014
Q2 | $477K | Buy |
+21,131
| New | +$477K | 0.04% | 384 |
|
|
2013
Q4 | $948K | Sell |
37,920
-3,975
| -9% | -$99.4K | 0.1% | 210 |
|
|
2013
Q3 | $1.15M | Sell |
41,895
-13,750
| -25% | -$378K | 0.12% | 177 |
|
|
2013
Q2 | $1.01M | Buy |
+55,645
| New | +$1.01M | 0.12% | 172 |
|